Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancer
-
D'Andrea, David (Medical University of Vienna. Department of Urology)
;
Soria, F. (University of the Studies of Turin. Division of Urology.) ;
Grotenhuis, A.J. (Radboud University Medical Centre. Department of Urology) ;
Cha, E.K. (Memorial Sloan Kettering Cancer Center Department of Urology) ;
Malats, Núria (Centro Nacional de Investigaciones Oncológicas) ;
Di Stasi, S. (Policlinico Tor Vergata-University of Rome. Department of Urology.) ;
Joniau, Steven (University Hospitals Leuven. Department of Urology.) ;
Cai, T. (Santa Chiara Hospital. Department of Urology) ;
van Rhijn, B.W.G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Irani, J. (University of Poitiers. Department of Urology.) ;
Karnes, J. (Mayo Clinic. Department of Urology) ;
Varkarakis, J. (University of Athens. Department of Urology) ;
Baniel, J. (Rabin Medical Centre. Department of Urology) ;
Palou, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Babjuk, Marek (University of Praha. Department of Urology.) ;
Spahn, M. (University Hospital of Wuerzburg. Department of Urology) ;
Ardelt, P. (Universitätsklinik Freiburg. Department of Urology) ;
Colombo, Renzo (Università Vita Salute. Department of Urology) ;
Serretta, V. (University of Palermo. Department of Surgical) ;
Dalbagni, G. (Memorial Sloan Kettering Cancer Center. Department of Urology) ;
Gontero, Paolo (Università degli Studi di Torino) ;
Bartoletti, R. (University of Pisa. Department of Translational Research and New Technologies) ;
Larré, S. (CHU de Reims. Department of Urology) ;
Malmström, Per-Uno (Uppsala University (Uppsala, Suècia)) ;
Sylvester, R. (European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel) ;
Shariat, S.F. (European Association of Urology Research Foundation)